Olympus Gains FDA Clearance for POWERSEAL Open Device
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEAL™ Open...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEAL™ Open...
AMSTERDAM, Netherlands, April 16, 2026 Royal Philips has announced a major advancement in medical imaging with the U.S. FDA...
NEW YORK, April 17, 2026 Intelligent Bio Solutions Inc. (INBS) has strengthened its upcoming FDA 510(k) submission by successfully...
PITTSBURGH, Pa., April 17, 2026 Xodus Medical, Inc. announced the launch of its Hot Pink Pad®, following FDA 510(k)...
NEW YORK, April 2, 2026 Intelligent Bio Solutions Inc. has achieved a critical milestone in its regulatory journey by...
SECAUCUS, N.J., Feb. 23, 2026 — The Vitamin Shoppe announced the launch of its inaugural “Suppies” Awards, a new...
TORONTO, Sept. 2, 2025 – Geneseeq Technology Inc. announced that its GeneseeqPrime® NGS Tumor Profiling Assay has received 510(k)...
